PL378275A1 - Bromowodorek escitalopramu i sposób jego wytwarzania - Google Patents

Bromowodorek escitalopramu i sposób jego wytwarzania

Info

Publication number
PL378275A1
PL378275A1 PL378275A PL37827503A PL378275A1 PL 378275 A1 PL378275 A1 PL 378275A1 PL 378275 A PL378275 A PL 378275A PL 37827503 A PL37827503 A PL 37827503A PL 378275 A1 PL378275 A1 PL 378275A1
Authority
PL
Poland
Prior art keywords
preparation
escitalopram hydrobromide
escitalopram
hydrobromide
Prior art date
Application number
PL378275A
Other languages
English (en)
Polish (pl)
Inventor
Lawrence Martel
Robert Dancer
Hans Petersen
Peter Ellegaard
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32668635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL378275(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of PL378275A1 publication Critical patent/PL378275A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL378275A 2002-12-23 2003-12-18 Bromowodorek escitalopramu i sposób jego wytwarzania PL378275A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200202005 2002-12-23

Publications (1)

Publication Number Publication Date
PL378275A1 true PL378275A1 (pl) 2006-03-20

Family

ID=32668635

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378275A PL378275A1 (pl) 2002-12-23 2003-12-18 Bromowodorek escitalopramu i sposób jego wytwarzania

Country Status (32)

Country Link
US (1) US20040167209A1 (enExample)
EP (1) EP1578738B1 (enExample)
JP (2) JP4658613B2 (enExample)
KR (1) KR20050086933A (enExample)
CN (1) CN100349885C (enExample)
AR (1) AR042652A1 (enExample)
AT (1) ATE388947T1 (enExample)
AU (1) AU2003287919B2 (enExample)
BR (1) BR0317623A (enExample)
CA (1) CA2511142A1 (enExample)
CY (1) CY1107451T1 (enExample)
DE (1) DE60319739T2 (enExample)
DK (1) DK1578738T3 (enExample)
EA (1) EA013116B1 (enExample)
EG (1) EG24729A (enExample)
ES (1) ES2298595T3 (enExample)
IL (1) IL169125A0 (enExample)
IS (1) IS2654B (enExample)
ME (1) MEP5808A (enExample)
MX (1) MXPA05005772A (enExample)
MY (1) MY135468A (enExample)
NO (1) NO20053595L (enExample)
NZ (1) NZ540281A (enExample)
PE (1) PE20040924A1 (enExample)
PL (1) PL378275A1 (enExample)
PT (1) PT1578738E (enExample)
RS (1) RS51092B (enExample)
TW (1) TW200501943A (enExample)
UA (1) UA80170C2 (enExample)
UY (1) UY28148A1 (enExample)
WO (1) WO2004056791A1 (enExample)
ZA (1) ZA200504109B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0317623A (pt) * 2002-12-23 2005-11-29 Lundbeck & Co As H Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
NZ549100A (en) * 2004-03-05 2010-02-26 Lundbeck & Co As H Crystalline composition containing escitalopram oxalate
TWI358407B (en) 2005-06-22 2012-02-21 Lundbeck & Co As H Crystalline base of escitalopram and orodispersibl
US7834201B2 (en) 2005-06-22 2010-11-16 H. Lundbeck A/S Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
US20070112075A1 (en) * 2005-10-14 2007-05-17 Forest Laboratories, Inc. Stable pharmaceutical formulations containing escitalopram and bupropion
EP1954257A4 (en) * 2005-10-14 2009-05-20 Lundbeck & Co As H METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
JP5501615B2 (ja) * 2006-07-11 2014-05-28 田辺三菱製薬株式会社 モルホリン化合物の塩
WO2008059514A2 (en) * 2006-07-31 2008-05-22 Cadila Healthcare Limited Process for preparing escitalopram
FR3006594A1 (fr) * 2013-06-11 2014-12-12 Sorin Crm Sas Microsonde implantable de detection/stimulation incorporant un agent anti-inflammatoire
CN108976188B (zh) * 2017-06-05 2022-12-06 上海奥博生物医药股份有限公司 一种艾司西酞普兰双羟萘酸盐新的制备方法
RU2020111694A (ru) * 2017-10-09 2021-11-12 Тева Фармасьютикал Индастриз Лтд. Новые соли и твердые формы эсциталопрама
EP4277661A1 (en) 2021-01-18 2023-11-22 Anton Frenkel Pharmaceutical dosage form

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US34712A (en) * 1862-03-18 James h
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB8419963D0 (en) * 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
ATE230738T1 (de) * 1998-10-20 2003-01-15 Lundbeck & Co As H Verfahren zur herstellung von citalopram
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
PT1298124E (pt) * 1999-10-25 2007-05-31 Lundbeck & Co As H Método para a preparação de citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
JP2002020379A (ja) * 2000-05-02 2002-01-23 Sumika Fine Chemicals Co Ltd シタロプラム臭化水素酸塩の結晶およびその結晶化方法
IES20010693A2 (en) * 2000-08-10 2002-07-10 Lundbeck & Co As H Pharmaceutical composition containing citalopram
WO2002046340A1 (de) * 2000-12-04 2002-06-13 Dr. Frische Gmbh Verfahren zur herstellung von fettsaüreestern
MXPA03008777A (es) * 2001-05-01 2004-02-12 Lundbeck & Co As H El uso de escitalopram enantiomericamente puro.
AR034612A1 (es) * 2001-06-25 2004-03-03 Lundbeck & Co As H Proceso para la preparacion del citalopram racemico y/o del s- o r-citalopram mediante la separacion de una mezcla de r- y s-citalopram
BR0317623A (pt) * 2002-12-23 2005-11-29 Lundbeck & Co As H Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
US20050174782A1 (en) * 2003-03-25 2005-08-11 Chapman Leonard T. Flashlight

Also Published As

Publication number Publication date
AR042652A1 (es) 2005-06-29
ATE388947T1 (de) 2008-03-15
DE60319739T2 (de) 2008-07-17
JP4658613B2 (ja) 2011-03-23
EA013116B1 (ru) 2010-02-26
WO2004056791A1 (en) 2004-07-08
RS20050487A (sr) 2007-06-04
IS2654B (is) 2010-08-15
AU2003287919A1 (en) 2004-07-14
ZA200504109B (en) 2006-08-30
JP2011037893A (ja) 2011-02-24
KR20050086933A (ko) 2005-08-30
CA2511142A1 (en) 2004-07-08
EP1578738B1 (en) 2008-03-12
PT1578738E (pt) 2008-04-11
DK1578738T3 (da) 2008-06-30
PE20040924A1 (es) 2004-12-11
MY135468A (en) 2008-04-30
AU2003287919B2 (en) 2009-11-12
EA200501046A1 (ru) 2005-12-29
DE60319739D1 (de) 2008-04-24
CN1726202A (zh) 2006-01-25
ES2298595T3 (es) 2008-05-16
CY1107451T1 (el) 2012-12-19
CN100349885C (zh) 2007-11-21
MXPA05005772A (es) 2005-08-16
TW200501943A (en) 2005-01-16
RS51092B (sr) 2010-10-31
NZ540281A (en) 2008-07-31
MEP5808A (xx) 2010-02-10
JP2006514952A (ja) 2006-05-18
EG24729A (en) 2010-06-21
UY28148A1 (es) 2004-09-30
EP1578738A1 (en) 2005-09-28
IS7848A (is) 2005-05-17
BR0317623A (pt) 2005-11-29
US20040167209A1 (en) 2004-08-26
HK1087708A1 (en) 2006-10-20
NO20053595L (no) 2005-09-05
UA80170C2 (en) 2007-08-27
IL169125A0 (en) 2009-02-11

Similar Documents

Publication Publication Date Title
GB0217425D0 (en) Patterning method
IL149978A0 (en) A biocide and method for making the same
ZA200201816B (en) A vaccine composition and method of using the same.
GB0215858D0 (en) Patterning method
EG24729A (en) Escitalopram hydrobromide and a method for the preparation thereof
AU2001251083A1 (en) Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
IL159175A0 (en) Patterning method
IL157609A0 (en) A vaccine composition and method of using the same
GB0315376D0 (en) A package assembly and a machine and method for the manufacture thereof
EP1534601A4 (en) SEALED FIXING FOR PAY
AU2003240410A8 (en) Piezoceramic composition, piezoceramic body comprising said composition and a method for producing said composition and said body
GB0030370D0 (en) A connecting rod and a method for making the same
EP1355548A4 (en) ANIMAL INJECTION MATERIAL AND METHOD FOR THE PRODUCTION OF SUIT THEREOF
AU2003281698A8 (en) 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
HUP0303553A3 (en) Plaster which contains steroids, and a method for the production and use thereof
AU2003208251A1 (en) Method for securing the leg of a machine and device for securing the leg of a machine
SI1578738T1 (sl) Escitalopram hidrobromid in postopek za pripravo le-tega
HUP0303889A3 (en) Fitting, and a method to produce it
AU2003304690A1 (en) A tool and a method for creating the tool
GB0200877D0 (en) A lightfitting and a method of packaging the same
HUP0500959A3 (en) Method for preparing latex
GB0226877D0 (en) An encapsulated product and a method for preparing and the use thereof
GB0320589D0 (en) Connection method
SI1565479T1 (sl) 2'-O-trisubstituiran sililoksimetil derivat ribonukleozida in nacin njegove priprave
EP1694401A4 (en) TOOL AND METHOD FOR PRODUCING IT

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)